David Bredt

RAPP

David Bredt serves as officer: Chief Scientific Officer at Rapport Therapeutics, Inc. Common Stock (RAPP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

14 trades

$2.41M

Net Position

Net Seller

$2.41M

Companies Traded

RAPP

Active Period

Mar 2025 – Feb 2026

14 total trades

Most Recent

Sell RAPP

Feb 19, 2026 · $246.7K

David Bredt's Insider Trading at Rapport Therapeutics, Inc. Common Stock (RAPP)

Buys

0 · $0.00

Sells

14 · $2.41M

Total Shares Bought

Total Shares Sold

117,067

RAPP Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 19, 2026	Sell	8,500	$29.02	$246.7K	394,675
Feb 17, 2026	Sell	8,500	$29.02	$246.7K	0
Jan 16, 2026	Sell	8,500	$26.84	$228.1K	395,775
Jan 5, 2026	Sell	6,567	$30.05	$197.3K	404,075
Dec 16, 2025	Sell	8,500	$30.02	$255.1K	393,438
Nov 18, 2025	Sell	8,500	$25.19	$214.1K	406,486
Oct 16, 2025	Sell	8,500	$25.79	$219.2K	410,724
Sep 17, 2025	Sell	8,500	$24.19	$205.6K	421,544
Aug 18, 2025	Sell	8,500	$15.00	$127.5K	426,842
Jul 16, 2025	Sell	8,500	$14.00	$119.0K	435,142
Jun 18, 2025	Sell	8,500	$11.00	$93.5K	443,642
May 19, 2025	Sell	8,500	$9.56	$81.3K	452,142
Apr 16, 2025	Sell	8,500	$9.57	$81.3K	460,642
Mar 17, 2025	Sell	8,500	$10.85	$92.2K	469,142